No Picture
Consumer

Dune, the Creatd-Owned (NASDAQ: CRTD) Wellness Drink, Launches at Urban Outfitters

NEW YORK, April 13, 2022 — Creatd, Inc. (NASDAQ: CRTD) (“Creatd” or the “Company”), a creator-first holding company, today announced the launch of a new partnership between Dune Glow Remedy (“Dune”), the Company’s owned-and-operated wellness beverage brand, and international […]

CEO Interview

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) “On-Ramp to Metaverse & Web 3.0 for $5 Trillion E-Commerce Market”

NEXT SUPER STOCK NexTech AR (OTC: NEXCF) (CSE: NTAR) is the On-Ramp to Metaverse & Web 3.0 for $5 Trillion E-Commerce Market. 4/5/22 livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s […]

Spotlight Stocks

Moderna, Inc. (NASDAQ: MRNA) CEO Stephane Bancel: ”Unique Opportunity to Transform Traditional Vaccine Market”

Moderna, Inc. (NASDAQ: MRNA) Vaccines Day Conference CEO Stephane Bancel Comments CEO Stephane Bancel: “…If you just look at the impact of vaccination on health over the last, let’s say, 20 years, it has been […]

CEO Interview

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) Advancing BioPharm Assets w Billion Dollar Markets

NEXT SUPER STOCK: PharmaDrug (OTC: LMLLF) (CSE: PHRX) CEO Daniel Cohen shares update on LMLLF’s Advancing BioPharma pipeline assets addressing billion dollar markets opportunities in cancer, and glaucoma therapeutics. March 30, 2022 livestream     […]

CEO Interview

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Billions Opportunity w/ autism psilocybin

NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” Update on  4/8/2022 livestream discussing clinical trial application […]